timing of metformi administration and exercise

Not Applicable

Completed

• Conditions: Nutritional, Metabolic, Endocrine

• Registration Number: PACTR202203690920424
• Lead Sponsor: Faculty of medicine of sousse

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2022-03-17
• Last Update Posted: 2023-05-29

Recruitment & Eligibility

• Status: Complete
• Sex: All
• Target Recruitment: 15

Inclusion Criteria

?Increased waist circumference (=102 cm in men; =88 cm in women)
?Elevated triglycerides (=150 mg/dl), or on medication for treating the condition
?Reduced HDL-cholesterol (<40mg/dl in men, <50 mg/dl in women), or on medication for treating the condition
?High blood pressure (=130 mmHg systolic or =85mmHg diastolic), or on medication for treating the condition
?Elevated fasting glucose (=100 mg/dl), or on medication for treating the condition

Exclusion Criteria

Any condition that counter-indicate exercise
Patients under glucose lowering agents

Study & Design

• Study Type: Interventional
• Study Design: Not specified